Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
Search
:::

郭錦松 (Chin-Sung Kuo)

郭錦松(Chin-Sung Kuo)圖 Return Appointment First Appointment

[Profile]

  • Education
    • 臨床醫學研究所 博士; 國立陽明交通大學,
    • 醫學系 醫學士; 國立陽明交通大學,
  • Career and Experience
    Current Positions：
    • - Now, 主治醫師, 內科部內分泌新陳代謝科, 臺北榮民總醫院,
    • - Now, 助理教授, 醫學系 , 國立陽明大學醫學院,
    • - Now, 監事, 中華民國內分泌學會,
    • - Now, 理事, 中華民國糖尿病衛教學會,
    • - Now, 理事長, 台灣甲狀腺協會,
    Experiences：
    • - , 研究員, 內分泌新陳代謝科, 美國加州大學 爾灣分校 ,
    • - , 助理教授, 內科, 慈濟大學醫學院,
    • - , 主任, 新陳代謝科, 大林慈濟醫院,
    • - , 講師, 醫學院, 國立陽明大學,
    • - , 總醫師, 內科部內分泌新陳代謝科, 臺北榮民總醫院,
    • - , 住院醫師, 內科部, 臺北榮民總醫院,
  • Medical Expertise
    1. 糖尿病、甲狀腺疾病、血脂異常
  • License
    中華民國內科專科醫師 中華民國內分泌暨新陳代謝科專科醫師 中華民國糖尿病衛教學會糖尿病衛教師 臺北市糖尿病共同照護網糖尿病認證醫師

[Publications]

第一作者

  • Kuo CS, Kuo NR, Yeh YK, Lee YJ, Chuang LM, Chen HF, Chen CC, Lee CC, Hsu CC, Li HY, Ou HY, Hwu CM. Residual risk of cardiovascular complications in statin-using patients with type 2 diabetes: the Taiwan Diabetes Registry Study. Lipids Health Dis. 2024 Jan 23. [IF 3.9]

共同第一作者

  • Kuo CS, Chen HS. β-cell function and long-term glycemic control in patients newly diagnosed with type 2 diabetes with moderate hyperglycemia after a 6-month course of basal insulin therapy. Diabetes Res Clin Pract. 2024 Aug 8. [IF 6.1]

通訊作者

  • Po-Sheng Lee, Jui-Yu Chen, Li-Hsin Pan, Chii-Min Hwu, Jen-Fan Hang, Chin-Sung Kuo. Unveiling a rare BRAF mutation in minimally invasive follicular thyroid carcinoma: A case report. Medicine. 2024 August 23 [IF 1.3]
  • Li-Hsin Pan, Jen-Fan Hang, Jui-Yu Chen, Po-Sheng Lee, Yun-Kai Yeh, Tai-Jung Huang, Chii-Min Hwu, Chin-Sung Kuo. Difficulties of Pre-operative Diagnosis of Cribriform Morular Thyroid Carcinoma: A Case Report. Case Rep Endocrinol. 2024 May 28. [IF 1.1]

共同作者

  • Lai HF, Hang JF, Kuo PC, Kuo CS, Yao SF, Chen JY, Lee CH. BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma. Ann Surg Oncol. 2024 Feb 1. [IF 3.4]
  • Lai HF, Hang JF, Kuo PC, Kuo CS*, Yao SF, Chen JY, Lee CH. BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma. Ann Surg Oncol. 2024 Feb 1. [IF 3.7]
  • Chen KL, Chou RH, Chang CC, Kuo CS*, Wei JH, Huang PH, Lin SJ. The high-density lipoprotein cholesterol (HDL-C)-concentration-dependent association between anti-inflammatory capacity and sepsis: A single-center cross-sectional study. PLoS One. 2024 Apr 11. [IF 3.7]
  • Shen FC, ……, Kuo CS*, …..., Sheu WH, Huang CN, Wang CY, Ou HY. Optimizing Lipid Control in Taiwanese Diabetic Patients: A Collaborative Consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators. Journal of Diabetes Investigation. 2024 Aug. [IF 3.2]
  • Jee-Fu Huang, ……, Chin-Sung Kuo, ……, Ming-Lung Yu. Taiwan Position Statement of Patients with Diabetes and Steatotic Liver Disease. Hepatology Communications 2024 accepted. [IF 5.6]
  • Chen CE, Guo JY, Chou RH, Wu CH, Kuo CS, Wei JH, Huang PH. Circulating corin concentration is associated with risk of mortality and acute kidney injury in critically ill patients. Sci Rep. 2024 Aug 27. [IF 3.8]
  • Huang JF, ……, Kuo CS, ……, Yu ML. Clinical care guidance in patients with diabetes and metabolic dysfunction-associated steatotic liver disease: A joint consensus. Hepatol Commun. 2024 Oct 30. [IF 5.6]
回到最上